Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Tyagarajan Seshu
Chief Technology Officer at Candel Therapeutics. Filing since 8 Dec 2022.
CIK 0001923794
Company
Date
Role
Action
Shares
Amount
Of holding
CADL
Candel Therapeutics, Inc.
17 Aug 2026
Chief Technology Officer
Sold on a plan
7,000
$84.00K
8.3%
CADL
Candel Therapeutics, Inc.
29 Jun 2026
Chief Technology Officer
Sold on a plan
7,000
$70.15K
7.7%
CADL
Candel Therapeutics, Inc.
17 Mar 2025
Chief Technology Officer
Sold on a plan
31,278
$275.95K
26.8%
CADL
Candel Therapeutics, Inc.
15 Jan 2025
Chief Technology Officer
Sold at will
14,322
$103.48K
12.9%
CADL
Candel Therapeutics, Inc.
8 Jan 2025
Chief Technology Officer
Sold at will
14,545
$119.53K
11.6%
CADL
Candel Therapeutics, Inc.
29 Nov 2024
Chief Technology Officer
Sold at will
20,392
$92.90K
14.0%
CADL
Candel Therapeutics, Inc.
17 Jul 2024
Chief Technology Officer
Sold at will
14,851
$96.12K
9.2%
CADL
Candel Therapeutics, Inc.
11 Jul 2024
Chief Technology Officer
Sold at will
13,330
$79.63K
7.7%
CADL
Candel Therapeutics, Inc.
9 Dec 2022
Chief Technology Officer
Bought
10,358
$19.99K
345%
CADL
Candel Therapeutics, Inc.
8 Dec 2022
Chief Technology Officer
Bought
3,000
$5.07K
opened
10 decisions on file.
